Earnings
CUE
12.91
+3.20%
0.40
Currencies: USD
Items
Total Revenue
Revenue
Cost of Revenue
Gross Profit
Marketing and Administrative Expenses
Research and Development Costs
Financial Expenses
Depreciation and Amortization
Other Expenses
Total Operating Expenses
Asset Impairments
Operating Income
Interest Income
Assets Disposal
Other Non-operating Net Income
Non-operating Income
Net Income Before Taxes
Provision for Income Taxes
Net Income
Minority Interests
Net Income Attributable to Shareholders
Net Income Attributable to Common Equities
Net Income from Discontinued Operations
Basic EPS
Diluted EPS
FY 2020-12-31
3.15M
3.15M
--
--
14.55M
32.59M
--
--
--
48.20M
--
-45.04M
463.91K
--
--
--
-44.58M
206.25K
-44.78M
--
-44.78M
-44.78M
--
--
-1.56
FY 2019-12-31
3.46M
3.46M
--
--
12.68M
26.75M
--
--
--
40.23M
--
-36.77M
418.71K
--
64.08K
--
-36.29M
412.50K
-36.70M
--
-36.70M
-36.70M
--
--
-1.67
FY 2018-12-31
1.14M
1.14M
--
--
11.26M
27.82M
--
--
--
39.84M
--
-38.70M
376.01K
--
165.34K
--
-38.16M
825.00K
-38.98M
--
-38.98M
-38.98M
--
--
-1.94
FY 2017-12-31
0.00
0.00
--
--
4.32M
18.50M
--
--
--
23.23M
--
-23.23M
40.00
--
--
--
-23.23M
--
-23.23M
--
-23.23M
-23.23M
--
--
-1.40
FY 2016-12-31
0.00
0.00
--
--
1.97M
5.49M
--
--
--
7.66M
--
-7.66M
50.00
--
--
--
-7.66M
0.00
-7.66M
--
-7.66M
-7.66M
--
--
-0.46

FY: Financial Year. It represents annual report.

Q: Quarter Report. Q1、Q2、Q3、Q4 represent three-month periodic financial reports.

Check out CUE latest quarterly and annual financial reports. There are also past financial reports for you to reference. You can analyze Cue Biopharma recent business situations from balance sheets, income statements, cash flow statements and other tables. This information may help you make smarter investment decisions.